ImmuONE

Hatfield, United Kingdom

ImmuONE provides translation studies, high content analysis, immune response, and interaction services.

$777K raised

Mar 2025

Seed

Top Investors

Mercia Ventures Midlands Engine Investment Fund Pioneer Group MEIF Proof-of-Concept & Early Stage Fund Mercia's EIS funds

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about ImmuONE

How much funding has ImmuONE raised?

ImmuONE has raised $777K in total funding. The most recent round was Seed. The last funding was announced in March 2025.

Who are ImmuONE's investors?

ImmuONE's investors include Mercia Ventures, Midlands Engine Investment Fund, Pioneer Group, MEIF Proof-of-Concept & Early Stage Fund, Mercia's EIS funds.

Where is ImmuONE headquartered?

ImmuONE is headquartered in Hatfield, United Kingdom.

What does ImmuONE do?

ImmuONE provides translation studies, high content analysis, immune response, and interaction services.

What stage is ImmuONE at?

ImmuONE is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 13, 2025.

MLA

"ImmuONE — Funding & Investors." VCBacked, March 13, 2025, https://www.vcbacked.co/company/immuone. Accessed July 1, 2026.

APA

VCBacked. (2025). ImmuONE — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/immuone

Wikipedia (cite web)

{{cite web |title=ImmuONE — Funding & Investors |url=https://www.vcbacked.co/company/immuone |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 13, 2025.

Similar Companies in Training

Duke Center for Autism and Brain Development